TELEMS: Feasibility of Remote Patient Visits in MS

NCT ID: NCT04838990

Last Updated: 2022-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-01

Study Completion Date

2021-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trials randomizes patients with multiple sclerosis (MS, pwMS) to a remote visit (via phone or videochat) or a regular outpatient visit. Outcomes include satisfaction on the patients' and doctor's side.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

conventional visit

Regular outpatient visit

Group Type ACTIVE_COMPARATOR

EDSS

Intervention Type OTHER

Neurological Exam - EDSS (Expanded Disability Status Scale)

Discussion of symptoms, Patient reported outcome (MSIS)

Intervention Type OTHER

Patients will be asked about their wellbeing

phone visit

Remote visit via phone

Group Type EXPERIMENTAL

EDSS

Intervention Type OTHER

Neurological Exam - EDSS (Expanded Disability Status Scale)

Discussion of symptoms, Patient reported outcome (MSIS)

Intervention Type OTHER

Patients will be asked about their wellbeing

video visit

Remote visit via videochat

Group Type EXPERIMENTAL

EDSS

Intervention Type OTHER

Neurological Exam - EDSS (Expanded Disability Status Scale)

Discussion of symptoms, Patient reported outcome (MSIS)

Intervention Type OTHER

Patients will be asked about their wellbeing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EDSS

Neurological Exam - EDSS (Expanded Disability Status Scale)

Intervention Type OTHER

Discussion of symptoms, Patient reported outcome (MSIS)

Patients will be asked about their wellbeing

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* confirmed diagnosis of any type of MS
* own a phone/smartphone/computer
* informed consent

Exclusion Criteria

* language barriers
Minimum Eligible Age

16 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Patrick Altmann MD PhD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patrick Altmann, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

References

Explore related publications, articles, or registry entries linked to this study.

Altmann P, Leutmezer F, Ponleitner M, Ivkic D, Krajnc N, Rommer PS, Berger T, Bsteh G. Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial. Digit Health. 2022 Jul 11;8:20552076221112154. doi: 10.1177/20552076221112154. eCollection 2022 Jan-Dec.

Reference Type DERIVED
PMID: 35847524 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2157/2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.